NASDAQ · Medical - Devices

BrainsWay Ltd. (BWAY) Stock

$16.56 +2.54% NASDAQ: BWAY Healthcare

BrainsWay Ltd. develops and distributes non-invasive neurostimulation therapies that address a broad spectrum of mental health and neurological conditions.

Valuation

MetricValue
Price$16.56
Market Cap$649.53M
P/E Ratio72.48
P/B Ratio8.22
P/S Ratio10.83
EPS (TTM)$0.22
52-Week High$17.35
52-Week Low$5.68
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE12.28%
ROA7.54%
ROCE6.54%
Gross Margin75.50%
Operating Margin10.09%
Net Margin14.57%
Debt/Equity0.09
Current Ratio3.34

Annual Financials (USD)

Metric20212022202320242025
Revenue$30.0M$27.0M$32.0M$41.0M$52.0M
Operating Profit$-5.0M$-13.0M$-5.0M$1.0M$4.0M
Net Profit$-6.0M$-13.0M$-4.0M$3.0M$8.0M
EPS$-0.21$-0.43$-0.13$0.09$0.36
Op Margin-16.9%-46.7%-15.6%3.4%8.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$76.0M$64.0M$63.0M$94.0M$113.0M
Total Liabilities$18.0M$19.0M$21.0M$32.0M$40.0M
Cash$17.0M$48.0M$11.0M$69.0M$68.0M
Borrowings$1.0M$0$0$6.0M$7.0M

Latest News

BrainsWay Announces Minority-Stake Investment in Sound Minds Behavioral GlobeNewswire · Jul 16, 2026 Best Momentum Stocks to Buy for July 14th Zacks · Jul 14, 2026 Is AtaiBeckley Inc (ATAI) Stock Outpacing Its Medical Peers This Year? Zacks · Jul 14, 2026 New Strong Buy Stocks for July 14th Zacks · Jul 14, 2026 BrainsWay Presents Positive Data from Largest Real-World Study of Deep TMS™ in Patients with Comorbid PTSD and Major Depressive Disorder GlobeNewswire · Jun 29, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$1.0M$-10.0M$1.0M$10.0M$18.0M
Investing Cash Flow$-44.0M$52.0M$-40.0M$27.0M$-19.0M
Financing Cash Flow$0$-1.0M$-1.0M$2.0M$-1.0M
Net Cash Flow$0$31.0M$-37.0M$59.0M$-2.0M
Free Cash Flow$-1.0M$-10.0M$-1.0M$7.0M$16.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.79
EV / EBITDA82.72
FCF Yield1.71%
Quick Ratio3.04
Interest Coverage2.89
Return 1Y173.72%
Return 3Y1282.88%
Return 5Y266.78%

Ownership

Insiders Held6.03%
Institutions Held29.82%
Institutions Float Held31.73%
Institutional HolderSharesReport Date
Valor Management LLC5,314,9502026-03-31
Masters Capital Management, LLC1,650,0002026-03-31
Acadian Asset Management. LLC818,2722026-03-31
Essex Investment Management Co LLC618,5532026-03-31
Renaissance Technologies, LLC518,4202026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CERS $2.32 +2.20% -34.25 $467.54M 0.00%
CVRX $4.88 +2.95% -2.98 $129.50M 0.00%
DCTH $15.11 -2.33% 157.43 $521.62M 0.00%
MASS $8.30 -1.31% 12.81 $340.53M 0.00%
NPCE $13.50 +4.73% -23.92 $460.27M 0.00%

About BrainsWay Ltd.

BrainsWay Ltd. develops and distributes non-invasive neurostimulation therapies that address a broad spectrum of mental health and neurological conditions. The company operates globally, with a presence in the United States, Europe, and Israel, among other international markets. Its primary offering is the Deep Transcranial Magnetic Stimulation (dTMS) platform technology, which provides treatment for various ailments including major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post-stroke rehabilitation, and Parkinson's disease. BrainsWay's clientele primarily comprises medical professionals, hospitals, and medical centers specializing in psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.

BrainsWay Ltd. is headquartered in IL.

BrainsWay Ltd. (BWAY) stock trades at $16.56 with a market capitalization of $649.53M. The stock is valued at a price-to-earnings (P/E) ratio of 72.48, price-to-book of 8.22, price-to-sales of 10.83. Over the past 52 weeks the stock has ranged between $5.68 and $17.35, and currently trades 4.6% below its 52-week high.

On profitability, BrainsWay Ltd. generates a return on equity (ROE) of 12.28%, above the typical market average, return on capital employed of 6.54%, an operating margin of 10.09%, a net profit margin of 14.57%.

Official website: www.brainsway.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides